Cigna Corporation

(New York Stock Exchange)
Back to all articles
Bullish +65

As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit

AI-generated analysis

πŸ“ˆ Cigna reported second-quarter net income of $1.66 billion ($6.29 per share), a significant increase from $1.53 billion in the same period last year.

πŸ’° Total revenues grew 7% year-over-year to reach $71.7 billion, driven by growth in Cigna Healthcare and Evernorth Health Services segments.

πŸ“Š The company raised its 2026 earnings outlook to at least $30.45 per share, beating the prior forecast of $30.35 per share.

πŸ₯ Medical cost ratio increased to 84.5% in Q2, primarily due to prior year risk adjustments rather than current claim volatility.

πŸ”„ Cigna remains competitive with a medical cost ratio significantly lower than rivals exceeding 90% in the industry.

πŸš€ New CEO Brian Evanko is executing a strategy focused on technology and AI to improve customer experiences and operational efficiency.

πŸ“‰ The company is strategically exiting government-subsidized markets, including the sale of Medicare businesses to HCSC and plans to exit individual ACA plans in 2027.

πŸ‘€ This financial report represents the first under the leadership of President and CEO Brian Evanko, who assumed the role on July 1.

Bullish Signals
  • Cigna reported a strong beat with net income rising to $1.66 billion compared to $1.53 billion in the prior year.
  • The company successfully raised its 2026 earnings guidance to at least $30.45 per share, indicating confidence in future performance.
  • Revenue increased by 7% to $71.7 billion, demonstrating resilient top-line growth amidst sector headwinds.
  • Cigna's medical cost ratio of 84.5% is notably lower than many competitors facing ratios above 90%, highlighting a competitive advantage.
  • Growth was driven by core segments Cigna Healthcare and Evernorth Health Services, validating the company's strategic focus.
Risk Factors
  • The medical cost ratio rose to 84.5% from 83.2% in the prior year, reflecting continued pressure from elevated medical expenses.
  • A portion of the increased medical costs is attributed to higher prior year risk adjustments recognized in individual and family plans.
Full Analysis
The Cigna Group reported robust second-quarter financial results under new CEO Brian Evanko, posting net income of nearly $1.7 billion ($6.29 per share) and a 7% revenue increase to $71.7 billion. This performance marks the first quarterly report since Evanko took over from David Cordani in July, demonstrating immediate strategic continuity despite industry-wide challenges. Despite elevated medical costs affecting the broader health insurance sector, Cigna's medical cost ratio rose slightly to 84.5% but remains lower than many competitors facing ratios above 90%. The company attributes part of this increase to prior year risk adjustments in individual plans rather than a fundamental deterioration in its core business operations. Cigna confidently raised its full-year 2026 earnings outlook to at least $30.45 per share, up from the previous forecast of $30.35. The growth was primarily driven by Cigna Healthcare and Evernorth Health Services, while the company continues to strategically exit lower-margin government-subsidized markets like Medicare Advantage and individual ACA plans. CEO Brian Evanko emphasized a strategy leveraging technology, data, and artificial intelligence to enhance customer experiences and reduce costs. He stated that these strong results reflect continued progress against their priorities of improving access and lowering costs for patients, validating the effectiveness of their current execution.